ImmuCell Corporation (ICCC) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 4.44M USD | Liabilities, Current |
| Cash and equivalents | 8.86M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.90M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 9.08M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.44M | $8.86M | (m) | $2.90M | $9.08M | (m) |
| 2026-03-31 | (m) | $3.91M | $6.81M | (m) | $2.69M | $8.67M | (m) |
| 2025-12-31 | (m) | $3.98M | $3.81M | (m) | $3.42M | $9.27M | (m) |
| 2025-09-30 | (m) | $4.00M | $3.89M | (m) | $2.55M | $9.80M | (m) |
| 2025-06-30 | (m) | $4.45M | (m) | (m) | $2.38M | $8.29M | (m) |
| 2025-03-31 | (m) | $3.87M | (m) | (m) | $3.35M | $7.36M | (m) |
| 2024-12-31 | (m) | $4.41M | (m) | (m) | $3.77M | $7.11M | (m) |
| 2024-09-30 | (m) | $4.47M | (m) | (m) | $2.31M | $7.46M | (m) |
| 2024-06-30 | (m) | $4.56M | $1.32M | (m) | $1.95M | $7.30M | (m) |
| 2024-03-31 | (m) | $4.18M | $960.35K | (m) | $2.62M | $7.15M | (m) |
| 2023-12-31 | (m) | $4.20M | $978.74K | (m) | $2.19M | $7.81M | (m) |
| 2023-09-30 | (m) | $3.33M | $1.99M | (m) | $1.86M | $7.39M | (m) |
| 2023-06-30 | (m) | $4.19M | (m) | (m) | $1.50M | $7.54M | (m) |
| 2023-03-31 | (m) | $3.84M | $3.10M | (m) | $2.09M | $6.33M | (m) |
| 2022-12-31 | (m) | $3.07M | $5.79M | (m) | $1.76M | $6.04M | (m) |
| 2022-09-30 | (m) | $2.71M | $8.83M | (m) | $1.70M | $5.32M | (m) |
| 2022-06-30 | (m) | $2.51M | $11.04M | (m) | $1.41M | $4.60M | (m) |
| 2022-03-31 | (m) | $2.35M | $11.82M | (m) | $2.65M | $3.44M | (m) |
| 2021-12-31 | (m) | $2.53M | $10.19M | (m) | $2.69M | $3.09M | (m) |
| 2021-09-30 | (m) | $2.17M | $10.50M | (m) | $2.42M | $2.67M | (m) |
| 2021-06-30 | (m) | $2.03M | $10.70M | (m) | $2.05M | $2.42M | (m) |
| 2021-03-31 | (m) | $2.10M | $6.81M | (m) | $2.39M | $2.12M | (m) |
| 2020-12-31 | (m) | $2.21M | $6.95M | (m) | $1.80M | $2.09M | (m) |
| 2020-09-30 | (m) | $1.80M | $3.92M | (m) | $1.54M | $2.09M | (m) |
| 2020-06-30 | (m) | $2.38M | $6.20M | (m) | $982.85K | $1.89M | (m) |
| 2020-03-31 | (m) | $1.86M | $6.51M | (m) | $1.88M | $1.60M | (m) |
| 2019-12-31 | (m) | $2.50M | $6.29M | (m) | $1.64M | $2.52M | (m) |
| 2019-09-30 | (m) | $2.23M | $2.35M | (m) | $886.71K | $2.68M | (m) |
| 2019-06-30 | (m) | $1.71M | $1.30M | (m) | $931.49K | $2.49M | (m) |
| 2019-03-31 | (m) | $2.02M | $10.58M | (m) | $1.28M | $2.04M | (m) |
| 2018-12-31 | (m) | $2.57M | $2.52M | (m) | $932.30K | $2.33M | (m) |
| 2018-09-30 | (m) | $1.93M | $2.39M | (m) | $853.97K | $2.25M | (m) |
| 2018-06-30 | (m) | $1.37M | $2.51M | (m) | $985.22K | $1.84M | (m) |
| 2018-03-31 | (m) | $1.41M | $3.06M | (m) | $999.90K | $1.93M | (m) |
| 2017-12-31 | (m) | $2.06M | $3.80M | (m) | $1.34M | $2.05M | (m) |
| 2017-09-30 | (m) | $3.58M | $2.31M | (m) | $868.92K | $2.73M | (m) |
| 2017-06-30 | (m) | $4.25M | $3.85M | (m) | $705.02K | $2.62M | (m) |
| 2017-03-31 | (m) | $1.76M | $4.25M | (m) | $1.01M | $2.10M | (m) |
| 2016-12-31 | (m) | $2.06M | $5.15M | (m) | $992.39K | $2.13M | (m) |
| 2016-09-30 | (m) | $1.05M | $4.41M | (m) | $677.15K | $1.77M | (m) |
| 2016-06-30 | (m) | $1.09M | $3.65M | (m) | $947.29K | $1.23M | (m) |
| 2016-03-31 | (m) | $890.35K | $4.56M | (m) | $1.46M | $980.90K | (m) |
| 2015-12-31 | (m) | $817.59K | $1.57M | (m) | $754.10K | $870.21K | (m) |
| 2015-09-30 | (m) | $679.89K | $2.47M | (m) | $789.21K | $864.44K | (m) |
| 2015-06-30 | (m) | $583.81K | $1.93M | (m) | $734.97K | $646.11K | (m) |
| 2015-03-31 | (m) | $709.24K | $2.47M | (m) | $754.85K | $578.66K | (m) |
| 2014-12-31 | (m) | $1.01M | $850.03K | (m) | $1.01M | $945.75K | (m) |
| 2014-09-30 | (m) | $824.63K | $1.17M | (m) | $563.56K | $1.04M | (m) |
| 2014-06-30 | (m) | $825.68K | $1.70M | (m) | $428.43K | $944.20K | (m) |
| 2014-03-31 | (m) | $841.67K | $2.24M | (m) | $720.03K | $947.33K | (m) |
| 2013-12-31 | (m) | $635.62K | $2.27M | (m) | $631.41K | $1.21M | (m) |
| 2013-09-30 | (m) | $566.48K | $2.94M | (m) | $376.09K | $1.49M | (m) |
| 2013-06-30 | (m) | $893.12K | $2.44M | (m) | $531.00K | $1.57M | (m) |
| 2013-03-31 | (m) | $584.83K | $2.32M | (m) | $689.60K | $1.44M | (m) |
| 2012-12-31 | (m) | $665.77K | $2.67M | (m) | $574.15K | $1.65M | (m) |
| 2012-09-30 | (m) | $549.90K | $1.59M | (m) | $432.29K | $1.80M | (m) |
| 2012-06-30 | (m) | $519.20K | $1.03M | (m) | $357.80K | $1.67M | (m) |
| 2012-03-31 | (m) | $641.95K | $1.57M | (m) | $594.57K | $1.58M | (m) |
| 2011-12-31 | (m) | $635.00K | $781.52K | (m) | $346.45K | $1.67M | (m) |
| 2011-09-30 | (m) | $606.93K | $563.54K | (m) | $420.92K | $1.76M | (m) |
| 2011-06-30 | (m) | $888.48K | $891.25K | (m) | $487.64K | $1.64M | (m) |
| 2011-03-31 | (m) | (m) | $887.43K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $525.02K | $1.40M | (m) | $465.28K | $1.60M | (m) |
| 2010-09-30 | (m) | (m) | $2.83M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $1.74M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $975.49K | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $1.20M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |